Tradestie Institutional Equity Comparison Engine

UCL vs UPC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

UCL Overall Edge

UCL Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to uCloudlink Group Inc. American Depositary Shares (UCL) driven by superior Valuation, Momentum & Technical while UPC counters with relative strength in Growth & Margin. Fundamentally, UCL trades at 14.4x Forward P/E with -16.6% operating margin (+1.1% YoY revenue) versus UPC at N/M Forward P/E and -11.8% operating margin (-1.3% YoY). In options structure, UCL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against UPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner UCL
UCL 14.4x vs UPC N/M Fwd P/E
Growth & Margin Winner UPC
Op Margin -16.6% vs -11.8% ยท YoY +1.1% vs -1.3%
Momentum & Technical Winner UCL
1Y -91.2% vs -69.8% ยท 52W Pos 2% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
UCL NASDAQ
uCloudlink Group Inc. American Depositary Shares
Communications Services, Nec
$0.21
-3.43% 1D
Market Cap $8.2M
1M Return -9.04%
1Y Return -91.22%
Forward P/E 14.4x
Unified AI Score
50.0 / 100 HOLD
Tech 67.0 Fund 61.0 Flow 50.0 Mom 68.9
UPC NASDAQ
Universe Pharmaceuticals Inc. Ordinary Shares
Pharmaceutical Preparations
$1.08
-20.59% 1D
Market Cap $6.8M
1M Return -75.34%
1Y Return -69.75%
Forward P/E N/M
Unified AI Score
41.4 / 100 SELL
Tech 25.0 Fund 53.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UCL -91.22% UPC -69.75% Spread: +21.7 pp (UPC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UCL TTM Op. Margin: -16.6% UPC TTM Op. Margin: -11.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UCL vs UPC. Trailing 12-month operating profitability (UCL -16.6% vs UPC -11.8%) and valuation multiples (UCL 14.4x vs UPC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UCL (6) vs UPC (3)
Institutional Metric UCL UPC Criterion Row Winner
Market Capitalization Scale $8.2M $6.8M Larger Scale Tie
Trailing P/E Ratio Valuation 14.4x N/M Lower Multiple UCL
Forward P/E Ratio Valuation 14.4x N/M Lower Multiple UCL
Revenue Growth (YoY) Growth +1.1% -1.3% Higher Growth UCL
Operating Margin (TTM) Profitability -16.6% -11.8% Higher Margin UPC
Net Profit Margin Profitability -12.6% -10.9% Higher Margin UPC
Return on Equity (ROE) Capital Efficiency -36.3% -3.5% Higher ROE UPC
52-Week Range Position Momentum 2% ($0โ€“$3) 0% ($1โ€“$18) Stronger Trend UCL
Beta / 30D Volatility Risk Regime 0.73ฮฒ ยท 129% Vol 4.56ฮฒ ยท 163% Vol Lower Realized Risk UCL
Unified Institutional Score Composite Signal 50.0 / 100 (HOLD) 41.4 / 100 (SELL) Higher Composite UCL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UCL vs UPC Buy Guide
UCL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UCL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UPC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UPC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UCL nor UPC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.